/Tag:methamphetamine

InterveXion Therapeutics, a UAMS Startup, Receives $14.5 Million to Develop Drug Therapies for Methamphetamine Users

LITTLE ROCK – A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.

By | January 29th, 2015|News Release, UAMS News|0 Comments

InterveXion and UAMS Complete First Drug Tests in Humans for Methamphetamine Addiction

LITTLE ROCK – InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.

By | December 19th, 2012|Media Contact - Taylor/Peel, UAMS News|0 Comments

First Human Tests of Meth Medication Completed

Dec. 19, 2012 | InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.

By | December 19th, 2012|UAMS News, University News|0 Comments

Anti-Meth Research Earns Student Award

May 29, 2012 | While no medication exists now for treating addiction to methamphetamine, UAMS graduate student Shraddha Thakkar and colleagues in the Graduate School and College of Medicine are working to change that.

By | May 29th, 2012|UAMS News, University News|0 Comments